HIGHLIGHTS   |  March 13, 2020   FDA Approves Isatuximab Combination for Previously Treated Multiple Myeloma The FDA approved isatuximab-irfc, in combination with pomalidomide and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least 2 prior therapies, including lenalidomide and a proteasome inhibitor. Read more   Guidelines for BIA-ALCL Provide Additional Guidance for Recognition and Diagnosis The new guidelines provide additional guidance for healthcare providers to better recognize and diagnose breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Read more   In Case You Missed It

Findings Show Resistance Mechanisms in Small Cell Lung Cancer A study, published in Nature Cancer, demonstrates the quick and evolving revolutions of resistance mechanisms in small cell lung cancer. Read more